We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.6B
AUM Growth
+$29.8M
Cap. Flow
-$1.17B
Cap. Flow %
-4.59%
Top 10 Hldgs %
14.11%
Holding
1,418
New
109
Increased
422
Reduced
606
Closed
147

Top Buys

Rank Stock Value
1
JMIA
Jumia Technologies
JMIA
+$130M
2
NXPI icon
NXP Semiconductors
NXPI
+$55.3M
3
AZO icon
AutoZone
AZO
+$42.3M
4
ALC icon
Alcon
ALC
+$35.7M
5
INTU icon
Intuit
INTU
+$33.7M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$126M
2
BIDU icon
Baidu
BIDU
+$83.8M
3
ROK icon
Rockwell Automation
ROK
+$76.1M
4
AMZN icon
Amazon
AMZN
+$74.9M
5
XLNX
Xilinx Inc
XLNX
+$56.7M

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 15.25%
3 Consumer Discretionary 10.67%
4 Financials 10.37%
5 Industrials 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
J icon
1176
Jacobs Solutions
J
$16B
$247K ﹤0.01%
+3,531
New +$228K
GBX icon
1177
The Greenbrier Companies
GBX
$1.57B
$246K ﹤0.01%
8,100
BEAT
1178
DELISTED
BioTelemetry, Inc.
BEAT
$246K ﹤0.01%
5,100
-63,100
-93% -$3.32M
BLCM
1179
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$239K ﹤0.01%
14,060
+10,490
+294% +$284K
NOV icon
1180
NOV
NOV
$6.84B
$237K ﹤0.01%
10,650
-4,944
-32% -$119K
ZVO
1181
DELISTED
Zovio Inc. Common Stock
ZVO
$237K ﹤0.01%
66,149
-9,200
-12% -$45.9K
BBBY
1182
Bed Bath & Beyond
BBBY
$479M
$236K ﹤0.01%
23,109
-130,888
-85% -$1.22M
AVID
1183
DELISTED
Avid Technology Inc
AVID
$233K ﹤0.01%
25,500
-76,200
-75% -$622K
IFF icon
1184
International Flavors & Fragrances
IFF
$20.3B
$232K ﹤0.01%
1,596
-85
-5% -$11.8K
PLAB icon
1185
Photronics
PLAB
$1.65B
$231K ﹤0.01%
+28,200
New +$251K
PDLI
1186
DELISTED
PDL BioPharma, Inc.
PDLI
$230K ﹤0.01%
+73,200
New +$237K
QRVO icon
1187
Qorvo
QRVO
$7.9B
$228K ﹤0.01%
3,429
+29
+0.9% +$2.02K
FCN icon
1188
FTI Consulting
FCN
$5.14B
$226K ﹤0.01%
2,700
PSCE icon
1189
Invesco S&P SmallCap Energy ETF
PSCE
$94M
$225K ﹤0.01%
4,990
+576
+13% +$28.3K
NSTG
1190
DELISTED
NanoString Technologies, Inc.
NSTG
$225K ﹤0.01%
+7,400
New +$196K
CHS
1191
DELISTED
Chicos FAS, Inc.
CHS
$225K ﹤0.01%
66,669
-16,331
-20% -$59.4K
PGNX
1192
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$225K ﹤0.01%
36,400
CARG icon
1193
CarGurus
CARG
$3.34B
$224K ﹤0.01%
6,201
EG icon
1194
Everest Group
EG
$15.6B
$220K ﹤0.01%
889
-212
-19% -$50.9K
XOMA
1195
DELISTED
Xoma
XOMA
$215K ﹤0.01%
14,488
-19,518
-57% -$293K
CVE icon
1196
Cenovus Energy
CVE
$54.2B
$214K ﹤0.01%
24,303
-176
-0.7% -$1.59K
RLJ icon
1197
RLJ Lodging Trust
RLJ
$1.88B
$214K ﹤0.01%
12,121
UPLD icon
1198
Upland Software
UPLD
$13.3M
$214K ﹤0.01%
470
-260
-36% -$119K
DLR icon
1199
Digital Realty Trust
DLR
$69.6B
$212K ﹤0.01%
1,799
WCG
1200
DELISTED
Wellcare Health Plans, Inc.
WCG
$212K ﹤0.01%
742
-728
-50% -$201K

Similar funds

Axa's Q2 2019 Portfolio in Review

As of Q2 2019, Axa held 1,418 positions worth $25.6B, up 0.12% from $25.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa withdrew a net $1.17B in Q2 2019, closing 147 positions and reducing 606 holdings. Its most notable exit was Foot Locker, an estimated $10.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Jumia Technologies worth $119M.

  • Axa's largest Q2 2019 buy was Jumia Technologies: 4,502,527 shares worth $119M.
  • Axa added most to NXP Semiconductors in Q2 2019, an estimated $55.3M increase.
  • Axa's biggest Q2 2019 reduction was Linde, cutting an estimated $126M.
  • Axa fully exited Foot Locker in Q2 2019, selling an estimated $10.1M.
  • Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q2 2019.
  • Axa opened 109 new positions and closed 147 in Q2 2019.
  • Axa's portfolio value rose 0.12% quarter-over-quarter to $25.6B.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.